![Dr. Sue Gail Eckhardt MD, Hematologist (Blood Specialist)](/fatd/images/avatar.png)
Dr. Sue Gail Eckhardt MD
Oncologist | Medical Oncology
1601 TRINITY ST AUSTIN TX, 78712About
Dr. Sue Eckhardt is an oncologist practicing in Aurora, CO. Dr. Eckhardt specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Eckhardt manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Provider Details
Expert Publications
Data provided by the National Library of Medicine- A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies.
- Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer.
- Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer.
- Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies.
- A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077.
- A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer.
- Plasma MMPs as surrogates of BAY 12-9566.
- Phase I and pharmacokinetic study of the differentiating agent vesnarinone in combination with gemcitabine in patients with advanced cancer.
- Development of matrix metalloproteinase inhibitors in cancer therapy.
- Matrix metalloproteinase inhibitors: how can we optimize their development?
- Phase I and pharmacokinetic study of NSC 655649, a rebeccamycin analog with topoisomerase inhibitory properties.
- Therapeutic angiogenesis inhibitors in the treatment of cancer.
- Angiogenesis inhibitors in clinical development for lung cancer.
- A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies.
- A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-times-five every-three-week schedule in patients with Advanced solid malignancies.
Dr. Sue Gail Eckhardt MD's Practice location
Practice At 12605 E 16th Ave
12605 E 16th Ave -Aurora, CO 80045Get Direction
Dr. Sue Gail Eckhardt MD's reviews
Write ReviewPatient Experience with Dr. Eckhardt
Recommended Articles
- Radiation Therapy vs Chemotherapy
Radiation TherapyIn this method, the doctors will use gamma rays, x-rays, and charged particles that will be directed at, implanted, or introduced directly into the blood stream. In this form of treatment, you will find the three types of therapy that will all be described according to way they...
- What Do Doctors Check in Prostate Cancer?
When we talk about prostate cancer, we are referring to a condition that affects the prostate gland. The condition is only found in men. The simple reason is that only men have the prostate gland. The prostate gland is located beneath a man's bladder and around the urethra. The primary function of...
- The Link Between Breast Implants and Lymphoma
Throughout the years, implants have risen in popularity. On an annual basis, about 400,000 women in the United States get breast implants – around 300,000 for cosmetic enlargement and around 100,000 for breast reconstruction after cancer. In the year 2015, it was estimated that 1.4 million women...
- Holistic Treatments for Lung Cancer
Lung CancerThere are two main groups of primary lung cancer: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). These two main groups are based on the way the tumors grow and spread. Lung cancer has the highest rate of death of all cancers in the US. The main causes of lung cancer...
- New Research Targets Stage Zero Breast Cancer
A new breast cancer diagnosis may provoke many questions. As baby boomers age, the possibility of cancer increases. Gen Xers and millennial's may also wonder about their risks, especially if breast cancer runs in the family.Receiving a diagnosis of “stage zero” breast cancer may be baffling....
- Estrogen Modulator for Breast Cancer
Hormone Receptor Breast CancerThere are certain types of breast cancer that are mostly affected by the hormones that are produced by the body. They are known as ER positive and PR positive breast cancer cells. These cells have receptors that are attached to the estrogen in the body. This estrogen...
Nearby Providers
- Anna Capasso MD1601 TRINITY ST AUSTIN TX 78712
- Tara Kaufmann MD1601 TRINITY ST AUSTIN TX 78712
- Kyaw Lwin Aung1601 TRINITY ST AUSTIN TX 78712
Nearest Hospitals
CHILDRENS HOSPITAL COLORADOl
13123 EAST 16TH AVENUE AURORA CO 80045SETON MEDICAL CENTER AUSTINl
1201 W 38TH ST AUSTIN TX 78705UNIVERSITY MEDICAL CENTER AT BRACKENRIDGEl
601 E 15TH STREET AUSTIN TX 78701ST DAVID'S MEDICAL CENTERl
919 E 32ND ST AUSTIN TX 78705